Ryan Watts
Founder at DENALI THERAPEUTICS INC.
Net worth: 33 M $ as of 29/04/2024
Ryan Watts active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DENALI THERAPEUTICS INC. | Director/Board Member | 13/10/2013 | - |
| Chief Executive Officer | 13/10/2013 | - | |
| Founder | 13/10/2013 | - | |
| President | 13/10/2013 | - | |
| Chief Tech/Sci/R&D Officer | 28/02/2015 | 31/07/2015 | |
Peel Therapeutics, Inc.
 Peel Therapeutics, Inc. BiotechnologyHealth Technology Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT. | Director/Board Member | 22/02/2023 | - |
Career history of Ryan Watts
Former positions of Ryan Watts
| Companies | Position | Start | End |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Founder | 31/12/2003 | 31/01/2015 |
| Corporate Officer/Principal | 31/12/2003 | 31/01/2015 |
Training of Ryan Watts
| University of Utah | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Director/Board Member | 2 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| DENALI THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Peel Therapeutics, Inc.
Peel Therapeutics, Inc. BiotechnologyHealth Technology Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT. | Health Technology |
- Stock Market
- Insiders
- Ryan Watts
- Experience
